BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 29, 2013
View Archived Issues
Identification and suppression of the neuronal circuitry underlying compulsive behavior
Read More
Studies characterize activity of Alzheimer's disease candidate RO-4602522
Read More
Effects of AZD-5213 on sleep evaluated in patients with MCI and Alzheimer's disease
Read More
GlaxoSmithKline profiles pipeline progress of second quarter 2013
Read More
Memory improvements seen with insulin detemir in Alzheimer's disease, mild cognitive impairment
Read More
Hemophilia candidate concizumab evaluated in phase I trial
Read More
Sanofi researchers report antibodies targeting IL-13
Read More
New GPR119 receptor agonists patented by Hyundai Pharmaceutical
Read More
The Terasaki Family Foundation prepares novel IVIg mimetics
Read More
FDA grants market authorization for Cepheid's tuberculosis test
Read More
Vertex provides update on ongoing VX-135 trials in hepatitis C
Read More
Yakult Honsha begins phase I/II study of resminostat in NSCLC
Read More
EMA committee recommends Defitelio approval under exceptional circumstances
Read More
EMA's CHMP recommends approval of VEGF Trap-Eye/Eylea for new indication
Read More
PolyTherics merges with Antitope
Read More
Phosphagenics reaches milestone in development program for TPM/oxycodone patch
Read More
Genesis Biopharma and Lion Biotechnologies complete merger
Read More
EMA committee recommends approval of Revolade expanded indication
Read More
EMA issues negative opinion on delamanid for tuberculosis
Read More
Captisol-enabled topiramate injection receives FDA orphan drug status
Read More
Adimab licenses antibody discovery platform to Biogen Idec and GSK
Read More
Novartis' dual bronchodilator QVA-149 recommended for approval in COPD by CHMP
Read More
Gilead receives positive opinion from EMA for cobicistat
Read More
EMA committee recommends approval of three Takeda type 2 diabetes therapies
Read More